Search Results - Thomas Elter

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Pharmacokinetics of alemtuzumab in combination with fludarabine in patients with relapsed or refractory B-cell chronic lymphocytic leukemia by Thomas Elter, Julia Kilp, Peter Borchmann, Holger Schulz, Michael Hallek, Andreas Engert

    Published in Haematologica (2009-01-01)
    Get full text
    Article


  2. 2

    Validation and implementation of a mobile app decision support system for prostate cancer to improve quality of tumor boards. by Yasemin Ural, Thomas Elter, Yasemin Yilmaz, Michael Hallek, Rabi Raj Datta, Robert Kleinert, Axel Heidenreich, David Pfister

    Published in PLOS Digital Health (2023-06-01)
    Get full text
    Article


  3. 3

    Versorgungsnahe Daten und agiles Projektmanagement – was hat das miteinander zu tun? by Prof. Dr. Volker Amelung, Prof. Dr. Wolfgang Hoffmann, PD Dr. Thomas Elter, Prof. Dr. Monika Klinkhammer-Schalke, Dr. Ursula Marschall, Dr. Oliver Schmalz

    Published in Monitor Versorgungsforschung (2023-12-01)
    Get full text
    Article


  4. 4

    Phase II study of central nervous system (CNS)-directed chemotherapy including high-dose chemotherapy with autologous stem cell transplantation for CNS relapse of aggressive lympho... by Agnieszka Korfel, Thomas Elter, Eckhard Thiel, Matthias Hänel, Robert Möhle, Roland Schroers, Marcel Reiser, Martin Dreyling, Jan Eucker, Christian Scholz, Bernd Metzner, Alexander Röth, Josef Birkmann, Uwe Schlegel, Peter Martus, Gerard Illerhaus, Lars Fischer

    Published in Haematologica (2013-03-01)
    Get full text
    Article


  5. 5

    Prognosis of patients with primary central nervous system lymphoma after high-dose chemotherapy followed by autologous stem cell transplantation by Elisabeth Schorb, Benjamin Kasenda, Johannes Atta, Stephan Kaun, Anke Morgner, Georg Hess, Thomas Elter, Nikolas von Bubnoff, Martin Dreyling, Mark Ringhoffer, Stefan W. Krause, Günter Derigs, Beate Klimm, D. Niemann, Kristina Fritsch, Jürgen Finke, Gerald Illerhaus

    Published in Haematologica (2013-05-01)
    Get full text
    Article


  6. 6

    Outcome of advanced chronic lymphocytic leukemia following different first-line and relapse therapies: a meta-analysis of five prospective trials by the German CLL Study Group (GCL... by Paula Cramer, Susanne Isfort, Jasmin Bahlo, Stephan Stilgenbauer, Hartmut Döhner, Manuela Bergmann, Martina Stauch, Michael Kneba, Elisabeth Lange, Petra Langerbeins, Natali Pflug, Gabor Kovacs, Valentin Goede, Anna-Maria Fink, Thomas Elter, Kirsten Fischer, Clemens-Martin Wendtner, Michael Hallek, Barbara Eichhorst

    Published in Haematologica (2015-11-01)
    Get full text
    Article


  7. 7

    Correction: Innovative Exercise in Routine Cancer Care: Insights from Eight Years of Integrated Oncological Exercise Therapy (OTT) by Timo Sonntag, Ariana Safi, Vera Coutellier, Anna Lorenz, Philipp Zimmer, Eva M. Zopf, Fiona Streckmann, Lars Gerland, Petra Wirtz-Derksen, Anja Großek, Anne Kollikowski, Constanze Handmann, Stefanie Siebert, Paul J. Bröckelmann, Christian P. Pallasch, Wilhelm Bloch, Thomas Elter, Michael Hallek, Damir Zubac, Freerk T. Baumann

    Published in Sports Medicine - Open (2026-06-01)
    Get full text
    Article


  8. 8

    Innovative Exercise in Routine Cancer Care: Insights from Eight Years of Integrated Oncological Exercise Therapy (OTT) by Timo Sonntag, Ariana Safi, Vera Coutellier, Anna Lorenz, Philipp Zimmer, Eva M. Zopf, Fiona Streckmann, Lars Gerland, Petra Wirtz-Derksen, Anja Großek, Anne Kollikowski, Constanze Handmann, Stefanie Siebert, Paul J. Bröckelmann, Christian P. Pallasch, Wilhelm Bloch, Thomas Elter, Michael Hallek, Damir Zubac, Freerk T. Baumann

    Published in Sports Medicine - Open (2026-03-01)
    Get full text
    Article


Search Tools: